{"filing":{"accession_number":"0001145197-26-000148","cik":"0001145197","ticker":"PODD","company_name":"INSULET CORP","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"podd-20260624.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519726000148/podd-20260624.htm"},"events":[{"id":13697,"run_id":12165,"accession_number":"0001145197-26-000148","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. Mazelsky brings significant executive experience, including 14 years at IDEXX Laboratories where he served as President and CEO, and prior leadership roles at Philips and Agilent.","company_name":"INSULET CORP","ticker":"PODD","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":10912,"accession_number":"0001145197-26-000148","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. The disclosure centers on his appointment to the Board, with detailed background on his executive experience as former President and CEO of IDEXX Laboratories. While the filing also mentions his director compensation (restricted stock units and cash), the principal disclosed action is the appointment itself, making this an exec_appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:07:40.434295+00:00","company_name":"","ticker":null,"filing_date":""},{"id":10913,"accession_number":"0001145197-26-000148","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Jonathan J. Mazelsky to Insulet's Board of Directors, effective July 1, 2026, as an independent director. The press release emphasizes his significant executive background, including 14 years at IDEXX where he served as President and CEO and doubled revenues and stock price, as well as prior leadership roles at Philips and Agilent. Board appointments of experienced executives with strong track records are material governance events affecting investor assessment of the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:07:40.434295+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10912,"accession_number":"0001145197-26-000148","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026. The disclosure centers on his appointment to the Board, with detailed background on his executive experience as former President and CEO of IDEXX Laboratories. While the filing also mentions his director compensation (restricted stock units and cash), the principal disclosed action is the appointment itself, making this an exec_appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:07:40.434295+00:00","company_name":"INSULET CORP","ticker":"PODD","filing_date":"2026-06-25"},{"id":10913,"accession_number":"0001145197-26-000148","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Jonathan J. Mazelsky to Insulet's Board of Directors, effective July 1, 2026, as an independent director. The press release emphasizes his significant executive background, including 14 years at IDEXX where he served as President and CEO and doubled revenues and stock price, as well as prior leadership roles at Philips and Agilent. Board appointments of experienced executives with strong track records are material governance events affecting investor assessment of the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T11:07:40.434295+00:00","company_name":"INSULET CORP","ticker":"PODD","filing_date":"2026-06-25"}]}